The Catalyst Issue 27 | May 2017 | Page 33

“The idea is to shrink the tumor away from these blood vessels and make surgery possible,” he says. The pancreas is a six-inch gland located in the abdomen, nestled among the stomach, small intestine, liver, spleen, gallbladder, and duodenum. With traditional radiation treatment, it is difficult to treat a tumor on the pancreas without delivering harmful doses of radiation to nearby healthy organs. SBRT allows radiation oncologists to focus narrowly on a spot within the pancreas. “With this type of technique, we’re able to limit the critical organs getting doses beyond their tolerance,” Dr. Pahlajani says. Innovation a nd patient success SBRT was used to treat tumors on the brain (where it is called stereotactic radiosurgery), and on the lungs and liver before physicians first began using it on the pancreas. However, the treatment remains novel for patients with pancreatic cancer, as few centers in the country are using it. Dr. Pahlajani was recruited to Scott & White Medical Center - Temple in January 2016 to develop an abdominal SBRT program, to include the pancreas. “This is still something that is in its infancy,” he says. As the treatment becomes more common, he predicts better outcomes for those suffering from pancreatic cancer. “We’ll see shifts in the remission rates pretty soon once this technique gains popularity,” he says. “It’s going to make a difference.” It already has made a difference Although pancreatic cancer is a particularly deadly cancer, it is not a common one. About 45,000 new cases of pancreatic cancer are diagnosed in the United States each year. Fortunately, Scott & White Medical Center- Temple is able to offer SBRT because it has the high patient volumes and physicians experienced in providing the latest, best treatments to patients with pancreatic cancer. Dr. Pahlajani noted that patients travel from up to four hours away to receive cancer treatment in Temple. “We do have a very large patient population here that can benefit from it,” he says. for Roselie Michelle Davis, from Brownwood. “Even though she couldn’t have surgery up front, she became a surgical candidate after receiving SBRT treatment,” Dr. Pahlajani says. “She had an excellent outcome.” Ms. Davis, age 54, was diagnosed with pancreatic cancer in early 2016 after receiving an MRI at Baylor Scott & White Medical Center - Round Rock. She was referred to Matthew Bower, MD, a surgical oncologist at Scott & White Medical Center in Temple, who outlined her treatment plan. She went through five months of chemotherapy before meeting with Dr. Pahlajani in July to begin SBRT treatment. “He always explained everything to me and made sure I understood what was happening,” Ms. Davis says. She received five doses of radiation over five consecutive days, which Dr. Pahlajani says is standard, and felt no side effects. Dr. Brower then performed surgery in September to remove the tumor. Five months later, Ms. Davis reported continuing improvement. “I’m feeling good,” she says. “I’m getting my strength back.” Dr. Pahlajani says SBRT can also be performed on patients who are not surgical candidates even after the tumor is reduced. “By using this technique on tumors that cannot be operated on, we help these patients as well by extending their life expectancy,” he says. He reports that one of his patients who received a combination of chemotherapy and SBRT has had “as good an outcome as if she had undergone surgery.” Patients receiving SBRT treatment must hold perfectly still for Dr. Pahlajani to target the tumor inside the pancreas. Patients are placed in a special, form-fitting couch that can be rotated to keep the body in the precise position required. Ms. Davis recalled, “Every time I went to a radiation treatment, my body was in the exact same position.” Each treatment lasts about 15 minutes. Dr. Pahlajani must also allow for a patient’s breathing. “We account for tumor motion during respiration,” he says, “so we can hit the tumor no matter where it is in the respiratory cycle.” Dr. Pahlajani’s expertise is being leveraged across the Baylor Scott & White Health system, as he trains colleagues at other locations. SBRT is now available at the Baylor Scott & White McClinton Cancer Center in Waco, as well. Dr. Pahlajani and his team continue to give new hope to patients with pancreatic cancer. n sw.org | Spring 17 THE CATALYST 33